James George to Humans
This is a "connection" page, showing publications James George has written about Humans.
Connection Strength
4.079
-
Hereditary Thrombotic Thrombocytopenic Purpura. Genes (Basel). 2023 10 18; 14(10).
Score: 0.051
-
Prevalence of neuropsychiatric symptoms and stroke in patients with hereditary thrombotic thrombocytopenic purpura. Blood. 2022 08 18; 140(7):785-789.
Score: 0.047
-
Thrombotic thrombocytopenic purpura: Crossing to safety. Transfusion. 2022 06; 62(6):1166-1170.
Score: 0.046
-
Morbidities and mortality in patients with hereditary thrombotic thrombocytopenic purpura. Blood Adv. 2022 02 08; 6(3):750-759.
Score: 0.045
-
Immune Thrombocytopenia Treatment. N Engl J Med. 2021 09 02; 385(10):948-950.
Score: 0.044
-
Recognizing and managing hereditary and acquired thrombotic thrombocytopenic purpura in infants and children. Pediatr Blood Cancer. 2021 05; 68(5):e28949.
Score: 0.042
-
TTP: the evolution of clinical practice. Blood. 2021 02 11; 137(6):719-720.
Score: 0.042
-
Frequency and severity of pregnancy complications in women with hereditary thrombotic thrombocytopenic purpura. Am J Hematol. 2020 11; 95(11):E316-E318.
Score: 0.041
-
Hereditary Thrombotic Thrombocytopenic Purpura. Reply. N Engl J Med. 2020 01 23; 382(4):394-395.
Score: 0.039
-
Stroke and myocardial infarction in hereditary thrombotic thrombocytopenic purpura: similarities to sickle cell anemia. Blood Adv. 2019 12 10; 3(23):3973-3976.
Score: 0.039
-
Treatment of Immune Thrombocytopenia in Adults: Version 2019. Mayo Clin Proc. 2019 11; 94(11):2161-2163.
Score: 0.039
-
Hereditary Thrombotic Thrombocytopenic Purpura. N Engl J Med. 2019 10 24; 381(17):1653-1662.
Score: 0.039
-
Preventable deaths during initial episodes of acquired Thrombotic Thrombocytopenic Purpura: Past and future. Am J Hematol. 2019 09; 94(9):E242-E244.
Score: 0.038
-
Embolic stroke of undetermined source in a young woman. Am J Hematol. 2019 09; 94(9):1044-1048.
Score: 0.038
-
Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura. N Engl J Med. 2019 07 04; 381(1):92-94.
Score: 0.038
-
Congenital TTP: toward a turning point. Blood. 2019 04 11; 133(15):1615-1617.
Score: 0.037
-
Additional autoimmune disorders in patients with acquired autoimmune thrombotic thrombocytopenic purpura. Am J Hematol. 2019 06; 94(6):E172-E174.
Score: 0.037
-
Drug-induced thrombocytopenia: 2019 Update of clinical and laboratory data. Am J Hematol. 2019 03; 94(3):E76-E78.
Score: 0.036
-
Maintenance rituximab for relapsing thrombotic thrombocytopenic purpura: a case report. Transfusion. 2019 03; 59(3):921-926.
Score: 0.036
-
TTP: long-term outcomes following recovery. Hematology Am Soc Hematol Educ Program. 2018 11 30; 2018(1):548-552.
Score: 0.036
-
Platelet sequestration and consumption in the placental intervillous space contribute to lower platelet counts during pregnancy. Am J Hematol. 2019 01; 94(1):E8-E11.
Score: 0.036
-
Platelet Counts during Pregnancy. N Engl J Med. 2018 10 18; 379(16):1581-1582.
Score: 0.036
-
Drug-induced thrombotic microangiopathy: An updated systematic review, 2014-2018. Am J Hematol. 2018 09; 93(9):E241-E243.
Score: 0.035
-
Platelet Counts during Pregnancy. N Engl J Med. 2018 Jul 05; 379(1):32-43.
Score: 0.035
-
The remarkable diversity of thrombotic thrombocytopenic purpura: a perspective. Blood Adv. 2018 06 26; 2(12):1510-1516.
Score: 0.035
-
The importance of clinical judgment for the diagnosis of thrombotic thrombocytopenic purpura. Transfusion. 2017 11; 57(11):2558-2561.
Score: 0.034
-
Diagnosis of thrombotic thrombocytopenic purpura among patients with ADAMTS13 Activity 10%-20. Am J Hematol. 2017 Nov; 92(11):E644-E646.
Score: 0.033
-
Platelet counts in women with normal pregnancies: A systematic review. Am J Hematol. 2017 Nov; 92(11):1224-1232.
Score: 0.033
-
A postpartum perfect storm. Am J Hematol. 2017 Oct; 92(10):1105-1110.
Score: 0.033
-
Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients. Am J Kidney Dis. 2017 Nov; 70(5):686-695.
Score: 0.033
-
Rituximab for thrombotic thrombocytopenic purpura: lessons from the STAR trial. Transfusion. 2017 10; 57(10):2532-2538.
Score: 0.033
-
After the Party's Over. N Engl J Med. 2017 Jan 05; 376(1):74-80.
Score: 0.032
-
Interferon-induced thrombotic microangiopathy. Blood. 2016 12 15; 128(24):2753-2754.
Score: 0.032
-
Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura. Blood. 2016 10 27; 128(17):2175-2178.
Score: 0.031
-
Depression in adult patients with primary immune thrombocytopenia. Am J Hematol. 2016 10; 91(10):E462-3.
Score: 0.031
-
Long-term outcomes of health-related quality of life following diverse thrombotic microangiopathy syndromes. Am J Hematol. 2016 Jun; 91(4):E278-9.
Score: 0.030
-
Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer. J Oncol Pract. 2016 06; 12(6):523-30.
Score: 0.030
-
Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2016 06 16; 127(24):3092-4.
Score: 0.030
-
Diversity and severity of adverse reactions to quinine: A systematic review. Am J Hematol. 2016 May; 91(5):461-6.
Score: 0.030
-
Cobalamin C deficiency-associated thrombotic microangiopathy: uncommon or unrecognised? Lancet. 2015 Sep 05; 386(9997):1012.
Score: 0.029
-
Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura. Am J Hematol. 2015 Aug; 90(8):709-14.
Score: 0.028
-
Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin. Am J Hematol. 2015 May; 90(5):406-10.
Score: 0.028
-
The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura. Blood. 2015 Mar 05; 125(10):1526-31.
Score: 0.028
-
Measuring ADAMTS13 activity in patients with suspected thrombotic thrombocytopenic purpura: when, how, and why? Transfusion. 2015 Jan; 55(1):11-3.
Score: 0.028
-
Syndromes of thrombotic microangiopathy associated with pregnancy. Hematology Am Soc Hematol Educ Program. 2015; 2015:644-8.
Score: 0.028
-
Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome: 2011 to 2014. Transfusion. 2014 Dec; 54(12):3257-9.
Score: 0.027
-
Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood. 2015 Jan 22; 125(4):616-8.
Score: 0.027
-
Syndromes of thrombotic microangiopathy. N Engl J Med. 2014 11 06; 371(19):1847-8.
Score: 0.027
-
Bone marrow necrosis discovered in a patient with suspected thrombotic thrombocytopenic purpura. Am J Hematol. 2015 Mar; 90(3):264-6.
Score: 0.027
-
Syndromes of thrombotic microangiopathy. N Engl J Med. 2014 Aug 14; 371(7):654-66.
Score: 0.027
-
Increased urinary albumin excretion following recovery from thrombotic thrombocytopenic purpura due to acquired ADAMTS13 deficiency. Am J Kidney Dis. 2014 Aug; 64(2):317-8.
Score: 0.026
-
N-Acetylcysteine: an old drug, a new insight, a potentially effective treatment for thrombotic thrombocytopenic purpura. Transfusion. 2014 May; 54(5):1205-7.
Score: 0.026
-
Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood. 2014 Mar 13; 123(11):1674-80.
Score: 0.026
-
Drug-induced thrombocytopenia in children. Pediatr Blood Cancer. 2013 Dec; 60(12):1975-81.
Score: 0.025
-
Complete remission of refractory immune thrombocytopenia (ITP) with a short course of Romiplostim. Eur J Haematol. 2013 Oct; 91(4):376-7.
Score: 0.025
-
Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood. 2013 Sep 19; 122(12):2023-9; quiz 2142.
Score: 0.025
-
Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer. 2013 Oct; 60(10):1676-82.
Score: 0.025
-
Conflicts of interest and clinical recommendations: comparison of two concurrent clinical practice guidelines for primary immune thrombocytopenia developed by different methods. Am J Med Qual. 2014 Jan-Feb; 29(1):53-60.
Score: 0.024
-
Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia. Semin Thromb Hemost. 2013 Mar; 39(2):153-60.
Score: 0.024
-
The Oklahoma Thrombotic Thrombocytopenic Purpura-haemolytic Uraemic Syndrome Registry. A model for clinical research, education and patient care. Hamostaseologie. 2013 May 29; 33(2):105-12.
Score: 0.024
-
Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency. J Clin Apher. 2012; 27(6):302-11.
Score: 0.023
-
Drug-induced thrombocytopenia: an updated systematic review, 2012. Drug Saf. 2012 Aug 01; 35(8):693-4.
Score: 0.023
-
A seasonal association of incident cases of thrombotic thrombocytopenic purpura was not observed in the Oklahoma TTP-HUS Registry. Transfusion. 2012 Jul; 52(7):1593-4; author reply 1594-5.
Score: 0.023
-
Determining a definite diagnosis of primary immune thrombocytopenia by medical record review. Am J Hematol. 2012 Sep; 87(9):843-7.
Score: 0.023
-
Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol. 2012 Sep; 87(9):848-52.
Score: 0.023
-
Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura. Am J Hematol. 2012 May; 87 Suppl 1:S88-91.
Score: 0.023
-
Sequence of treatments for adults with primary immune thrombocytopenia. Am J Hematol. 2012 May; 87 Suppl 1:S12-5.
Score: 0.023
-
Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer. Presse Med. 2012 Mar; 41(3 Pt 2):e177-88.
Score: 0.022
-
Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes. Hematology Am Soc Hematol Educ Program. 2012; 2012:604-9.
Score: 0.022
-
Children with ITP: looking beyond the platelet count. Pediatr Blood Cancer. 2012 Mar; 58(3):323-4.
Score: 0.022
-
Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol. 2011 Sep; 86(9):743-51.
Score: 0.022
-
Systemic malignancies as a cause of unexpected microangiopathic hemolytic anemia and thrombocytopenia. Oncology (Williston Park). 2011 Sep; 25(10):908-14.
Score: 0.022
-
Drug-induced thrombocytopenia: an updated systematic review, 2010. Drug Saf. 2011 May 01; 34(5):437-8.
Score: 0.021
-
Management of immune thrombocytopenia--something old, something new. N Engl J Med. 2010 Nov 11; 363(20):1959-61.
Score: 0.021
-
Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes. Am J Hematol. 2010 Nov; 85(11):844-7.
Score: 0.021
-
How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood. 2010 Nov 18; 116(20):4060-9.
Score: 0.020
-
The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol. 2010 Mar; 85(3):174-80.
Score: 0.020
-
Recurrent acute thrombocytopenia in the hospitalized patient: sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia. Am J Hematol. 2010 Jan; 85(1):71-4.
Score: 0.020
-
Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2010 Feb 25; 115(8):1500-11; quiz 1662.
Score: 0.019
-
Successful treatment of cyclic thrombocytopenia with thrombopoietin-mimetic agents: a report of two patients. Am J Hematol. 2009 Jul; 84(7):459-61.
Score: 0.019
-
Definition, diagnosis and treatment of immune thrombocytopenic purpura. Haematologica. 2009 Jun; 94(6):759-62.
Score: 0.019
-
Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clin Infect Dis. 2009 Apr 15; 48(8):1129-37.
Score: 0.019
-
Cognitive deficits after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009 Jun; 49(6):1092-101.
Score: 0.018
-
Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura. Transfusion. 2009 May; 49(5):873-87.
Score: 0.018
-
The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: evaluation, management, and long-term outcomes experience of the Oklahoma TTP-HUS Registry, 1989-2007. Kidney Int Suppl. 2009 Feb; (112):S52-4.
Score: 0.018
-
The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: overview of pathogenesis (Experience of The Oklahoma TTP-HUS Registry, 1989-2007). Kidney Int Suppl. 2009 Feb; (112):S8-S10.
Score: 0.018
-
ADAMTS13: what it does, how it works, and why it's important. Transfusion. 2009 Feb; 49(2):196-8.
Score: 0.018
-
Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008. Transfusion. 2009 Feb; 49(2):392-4.
Score: 0.018
-
Drug-induced thrombocytopenia: an updated systematic review, 2008. Drug Saf. 2009; 32(1):85-6.
Score: 0.018
-
Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematology Am Soc Hematol Educ Program. 2009; 153-8.
Score: 0.018
-
Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients. Br J Haematol. 2009 Mar; 144(5):742-54.
Score: 0.018
-
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009 Mar 12; 113(11):2386-93.
Score: 0.018
-
Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials. Br J Haematol. 2009 Feb; 144(3):409-15.
Score: 0.018
-
Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009 Jan; 49(1):118-24.
Score: 0.018
-
Novel thrombopoietic agents: a new era for management of patients with thrombocytopenia. Haematologica. 2008 Oct; 93(10):1445-9.
Score: 0.018
-
Clinical insights from observations on ADAMTS13 deficiency in liver cirrhosis. Thromb Haemost. 2008 Jun; 99(6):987-8.
Score: 0.017
-
Congenital thrombotic thrombocytopenic purpura: Lessons for recognition and management of rare syndromes. Pediatr Blood Cancer. 2008 May; 50(5):947-8.
Score: 0.017
-
Thrombotic thrombocytopenic purpura: 2008 update. Cleve Clin J Med. 2008 May; 75(5):369-75.
Score: 0.017
-
Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. Br J Haematol. 2008 May; 141(5):696-707.
Score: 0.017
-
Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease. Haematologica. 2008 Feb; 93(2):172-7.
Score: 0.017
-
The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: the Swiss connection. Eur J Haematol. 2008 Apr; 80(4):277-86.
Score: 0.017
-
Lessons learned from the Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry. J Clin Apher. 2008; 23(4):129-37.
Score: 0.017
-
Support groups for patients who have recovered from thrombotic thrombocytopenic purpura. J Clin Apher. 2008; 23(5):168-9.
Score: 0.017
-
Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review. Transfusion. 2008 Feb; 48(2):382-92.
Score: 0.017
-
Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006. Transfusion. 2008 Feb; 48(2):349-57.
Score: 0.017
-
Endemic Esherichia coil O157:H7 infections and hemolytic-uremic syndrome in Oklahoma, 2002-2005. J Okla State Med Assoc. 2007 Nov; 100(11):429-33.
Score: 0.017
-
Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica. 2007 Jul; 92(7):936-43.
Score: 0.016
-
The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a community service. J Okla State Med Assoc. 2007 Jul; 100(7):273-8.
Score: 0.016
-
Bilateral nephrectomy for treatment resistant systemic lupus erythematosis and thrombotic thrombocytopenic purpura: a case report. Am J Hematol. 2007 Jun; 82(6):496-7.
Score: 0.016
-
Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus. South Med J. 2007 May; 100(5):512-4.
Score: 0.016
-
Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation. Curr Opin Oncol. 2007 Mar; 19(2):148-54.
Score: 0.016
-
Evaluation and management of patients with thrombotic thrombocytopenic purpura. J Intensive Care Med. 2007 Mar-Apr; 22(2):82-91.
Score: 0.016
-
Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist. 2007 Jan; 12(1):11-9.
Score: 0.016
-
Drug-induced thrombocytopenia: an updated systematic review, 2006. Drug Saf. 2007; 30(2):185-6.
Score: 0.016
-
Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost. 2006 Aug; 4(8):1664-72.
Score: 0.015
-
Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med. 2006 May 04; 354(18):1927-35.
Score: 0.015
-
Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006 May; 12(5):506-10.
Score: 0.015
-
Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders. J Clin Apher. 2006 Apr; 21(1):49-56.
Score: 0.015
-
Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion. 2006 Jan; 46(1):154-6.
Score: 0.015
-
The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clin Adv Hematol Oncol. 2005 Aug; 3(8):627-32.
Score: 0.014
-
The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost. 2005 Jul; 3(7):1432-6.
Score: 0.014
-
ADAMTS13, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome. Curr Hematol Rep. 2005 May; 4(3):167-9.
Score: 0.014
-
Is immune thrombocytopenic purpura less common among black Americans? Blood. 2005 Feb 01; 105(3):1368-9.
Score: 0.014
-
Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura. Int J Hematol. 2005 Feb; 81(2):119-25.
Score: 0.014
-
Tibor Greenwalt Award. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a program for patient care, education and research. Transfusion. 2004 Sep; 44(9):1384-92.
Score: 0.013
-
Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion. 2004 Aug; 44(8):1149-58.
Score: 0.013
-
Recombinant ADAMTS13: an effective rescue therapy for acute cTTP during pregnancy. Blood Adv. 2024 Jul 23; 8(14):3718-3720.
Score: 0.013
-
ASH Guideline Oversight Subcommittee Response to Jacobs et al regarding Industry Payments to ASH Guideline Panelists. Blood Adv. 2024 Jul 09; 8(13):3553-3554.
Score: 0.013
-
Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004 Nov 01; 104(9):2623-34.
Score: 0.013
-
How can we provide the best care for our patients with immune thrombocytopenic pupura? Mayo Clin Proc. 2004 Apr; 79(4):456-7.
Score: 0.013
-
For low platelets, how low is dangerous? Cleve Clin J Med. 2004 Apr; 71(4):277-8.
Score: 0.013
-
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion. 2004 Feb; 44(2):294-304.
Score: 0.013
-
Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Ann Intern Med. 2004 Jan 20; 140(2):112-20.
Score: 0.013
-
Thrombotic thrombocytopenic purpura: advances in pathophysiology, diagnosis, and treatment--introduction. Semin Hematol. 2004 Jan; 41(1):1-3.
Score: 0.013
-
The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS. Semin Hematol. 2004 Jan; 41(1):60-7.
Score: 0.013
-
Idiopathic thrombocytopenic purpura in adults: current issues for pathogenesis, diagnosis and management. Hematol J. 2004; 5 Suppl 3:S12-4.
Score: 0.013
-
Thrombotic thrombocytopenic purpura: a syndrome that keeps evolving. J Clin Apher. 2004; 19(2):63-5.
Score: 0.013
-
Recent advances in thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2004; 407-23.
Score: 0.013
-
Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care. Am J Hematol. 2003 Nov; 74(3):161-9.
Score: 0.013
-
The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol. 2003 Sep; 10(5):339-44.
Score: 0.013
-
Idiopathic thrombocytopenic purpura: current issues for pathogenesis, diagnosis, and management in children and adults. Curr Hematol Rep. 2003 Sep; 2(5):381-7.
Score: 0.013
-
Immune thrombocytopenic purpura--let the treatment fit the patient. N Engl J Med. 2003 Aug 28; 349(9):903-5.
Score: 0.013
-
Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept. Am J Hematol. 2003 Jun; 73(2):135-40.
Score: 0.012
-
Complications of plasma exchange in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a study of 78 additional patients. Transfusion. 2003 Mar; 43(3):415-6.
Score: 0.012
-
Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community. Ann Intern Med. 2003 Jan 21; 138(2):152-3.
Score: 0.012
-
Occult recurrent breast cancer masquerading as thrombotic thrombocytopenic purpura. Am J Hematol. 2023 May; 98(5):830-832.
Score: 0.012
-
Salmonella sepsis caused by a platelet transfusion from a donor with a pet snake. N Engl J Med. 2002 Oct 03; 347(14):1075-8.
Score: 0.012
-
Idiopathic thrombocytopenic purpura and myelodysplastic syndrome: distinct entities or overlapping syndromes? Leuk Res. 2002 Sep; 26(9):789-90.
Score: 0.012
-
Aspirin prophylaxis for hereditary and acquired thrombotic thrombocytopenic purpura? Am J Hematol. 2022 08; 97(8):E304-E306.
Score: 0.012
-
Deletion of platelet CLEC-2 decreases GPIba-mediated integrin aIIbß3 activation and decreases thrombosis in TTP. Blood. 2022 04 21; 139(16):2523-2533.
Score: 0.011
-
Initial management of adults with idiopathic (immune) thrombocytopenic purpura. Blood Rev. 2002 Mar; 16(1):37-8.
Score: 0.011
-
Drug (vaccine)-induced thrombocytopenia 2021: Diversity of pathogenesis and clinical features. Am J Hematol. 2022 04; 97(4):E162-E165.
Score: 0.011
-
Platelets: thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2002; 315-34.
Score: 0.011
-
Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes. Ann Intern Med. 2001 Dec 18; 135(12):1047-51.
Score: 0.011
-
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: diagnosis and treatment. Cleve Clin J Med. 2001 Oct; 68(10):857-8, 860, 863-4 passim.
Score: 0.011
-
Severe thrombocytopenia and microangiopathic hemolytic anemia in pregnancy: A guide for the consulting hematologist. Am J Hematol. 2021 12 01; 96(12):1655-1665.
Score: 0.011
-
Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol. 2001 Sep; 8(5):286-93.
Score: 0.011
-
Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura. Blood. 2021 06 24; 137(25):3563-3575.
Score: 0.011
-
Redefining outcomes in immune TTP: an international working group consensus report. Blood. 2021 04 08; 137(14):1855-1861.
Score: 0.011
-
Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Bone Marrow Transplant. 2001 Mar; 27(6):641-6.
Score: 0.011
-
Unintentional platelet removal by plasmapheresis. J Clin Apher. 2001; 16(2):55-60.
Score: 0.010
-
Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy. J Clin Apher. 2001; 16(4):202-9.
Score: 0.010
-
Occult quinine-induced thrombocytopenia. J Okla State Med Assoc. 2000 Nov; 93(11):519-21.
Score: 0.010
-
How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood. 2000 Aug 15; 96(4):1223-9.
Score: 0.010
-
Management of patients with chronic, refractory idiopathic thrombocytopenic purpura. Semin Hematol. 2000 Jul; 37(3):290-8.
Score: 0.010
-
Platelets. Lancet. 2000 Apr 29; 355(9214):1531-9.
Score: 0.010
-
Shared decision making, thrombotic thrombocytopenic purpura, and caplacizumab. Am J Hematol. 2020 04; 95(4):E76-E77.
Score: 0.010
-
Treatment options for chronic idiopathic (immune) thrombocytopenic purpura. Semin Hematol. 2000 Jan; 37(1 Suppl 1):31-4.
Score: 0.010
-
Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists. J Pediatr Hematol Oncol. 2000 Jan-Feb; 22(1):55-61.
Score: 0.010
-
American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019 12 10; 3(23):3829-3866.
Score: 0.010
-
Acquired pure megakaryocytic aplasia report of two cases with long-term responses to antithymocyte globulin and cyclosporine. Am J Hematol. 1999 Oct; 62(2):115-7.
Score: 0.010
-
Drug-induced thrombocytopenia. Curr Opin Hematol. 1999 Sep; 6(5):349-53.
Score: 0.010
-
The evidence-based analysis of treatment for chronic myeloid leukemia: An introduction to its methods and clinical implications. Blood. 1999 Sep 01; 94(5):1515-6.
Score: 0.010
-
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) following treatment with deoxycoformycin in a patient with cutaneous T-cell lymphoma (Sezary syndrome): A case report. Am J Hematol. 1999 Aug; 61(4):268-70.
Score: 0.009
-
The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017. Haematologica. 2019 10; 104(10):2107-2115.
Score: 0.009
-
Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med. 1998 Dec 01; 129(11):886-90.
Score: 0.009
-
Idiopathic thrombocytopenic purpura: diagnosis and management. Am J Med Sci. 1998 Aug; 316(2):87-93.
Score: 0.009
-
Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologists. J Thromb Thrombolysis. 2018 Jul; 46(1):24-30.
Score: 0.009
-
Idiopathic thrombocytopenic purpura: a guideline for diagnosis and management of children and adults. American Society of Hematology. Ann Med. 1998 Feb; 30(1):38-44.
Score: 0.009
-
Idiopathic thrombocytopenic purpura: A concise summary of the pathophysiology and diagnosis in children and adults. Semin Hematol. 1998 Jan; 35(1 Suppl 1):5-8.
Score: 0.008
-
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: diagnosis and management. J Clin Apher. 1998; 13(3):120-5.
Score: 0.008
-
Successful kidney transplantation in a patient with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome). Transfusion. 2017 12; 57(12):3058-3062.
Score: 0.008
-
Clinical decisions in idiopathic thrombocytopenic purpura. Hosp Pract (1995). 1997 Sep 15; 32(9):159-60, 163-6, 169-70, passim.
Score: 0.008
-
Diagnosis, clinical course, and management of idiopathic thrombocytopenic purpura. Curr Opin Hematol. 1996 Sep; 3(5):335-40.
Score: 0.008
-
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996 Jul 01; 88(1):3-40.
Score: 0.008
-
Congenital thrombotic thrombocytopenic purpura related to a novel mutation in ADAMTS13 gene and management during pregnancy. Am J Hematol. 2016 06; 91(6):644-6.
Score: 0.008
-
The effect of an intense mentoring program on junior investigators' preparation for a patient-oriented clinical research career. Acad Med. 2015 Aug; 90(8):1061-6.
Score: 0.007
-
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000.
Score: 0.007
-
Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura. PLoS One. 2015; 10(2):e0117614.
Score: 0.007
-
Chronic idiopathic thrombocytopenic purpura. N Engl J Med. 1994 Nov 03; 331(18):1207-11.
Score: 0.007
-
Autoimmune hemolytic anemia and thrombocytopenia attributed to an intrauterine contraceptive device. Transfusion. 2015 Mar; 55(3):657-60.
Score: 0.007
-
Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists. Am J Med Sci. 2014 Mar; 347(3):190-4.
Score: 0.007
-
Irinotecan-induced immune thrombocytopenia. Am J Med Sci. 2014 Feb; 347(2):167-9.
Score: 0.006
-
Pulmonary involvement in patients with thrombotic thrombocytopenic purpura. Eur J Haematol. 2014 Feb; 92(2):156-63.
Score: 0.006
-
Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev. 2013 Jul; 27(3):137-45.
Score: 0.006
-
First symptoms in patients with thrombotic thrombocytopenic purpura: what are they and when do they occur? Transfusion. 2013 Jan; 53(1):235-7.
Score: 0.006
-
A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia. Eur J Haematol. 2013 Feb; 90(2):121-6.
Score: 0.006
-
Health care utilization of patients diagnosed with idiopathic thrombotic thrombocytopenic purpura in a commercially insured population in the United States. Transfusion. 2012 Jul; 52(7 Pt 2):1614-21.
Score: 0.006
-
Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion. 2012 Dec; 52(12):2525-32; quiz 2524.
Score: 0.006
-
Should all adult patients with diarrhoea-associated HUS receive plasma exchange? Lancet. 2012 Feb 11; 379(9815):516; author reply 516-7.
Score: 0.006
-
Changes in platelet membrane glycoproteins during blood bank storage. Blood Cells. 1992; 18(3):501-11; discussion 512-5.
Score: 0.006
-
Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica. 2012 Feb; 97(2):297-303.
Score: 0.006
-
Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency. Transfusion. 2011 Oct; 51(10):2237-43.
Score: 0.005
-
Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol. 2011 May; 86(5):420-9.
Score: 0.005
-
The clinical importance of acquired abnormalities of platelet function. N Engl J Med. 1991 Jan 03; 324(1):27-39.
Score: 0.005
-
Platelet immunoglobulin G: its significance for the evaluation of thrombocytopenia and for understanding the origin of alpha-granule proteins. Blood. 1990 Sep 01; 76(5):859-70.
Score: 0.005
-
Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood. 2010 Sep 23; 116(12):2127-33.
Score: 0.005
-
Thrombocytopenia as an adverse effect of complementary and alternative medicines, herbal remedies, nutritional supplements, foods, and beverages. Eur J Haematol. 2010 May; 84(5):421-9.
Score: 0.005
-
Validation of claims-based diagnostic codes for idiopathic thrombotic thrombocytopenic purpura in a commercially-insured population. Thromb Haemost. 2010 Jun; 103(6):1203-9.
Score: 0.005
-
Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med. 2010 Feb 18; 362(7):600-13.
Score: 0.005
-
Long-term, sub-clinical cardiac and renal complications in patients with multiple relapses of thrombotic thrombocytopenic purpura. Br J Haematol. 2010 May; 149(4):623-5.
Score: 0.005
-
Demographic and ADAMTS13 biomarker data as predictors of early recurrences of idiopathic thrombotic thrombocytopenic purpura. Eur J Haematol. 2009 Dec 01; 83(6):559-64.
Score: 0.005
-
Addendum to corticosteroid side effects and risk for bleeding in immune thrombocytopenic purpura: patient perspectives. Eur J Haematol. 2009 Nov; 83(5):497-8.
Score: 0.005
-
Referral of patients with thrombocytopenia from primary care clinicians to hematologists. Blood. 2009 Apr 23; 113(17):4126-7.
Score: 0.005
-
Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol. 2009 Sep; 83(3):175-82.
Score: 0.005
-
Severe vitamin B-12 deficiency in a child mimicking thrombotic thrombocytopenic purpura. Pediatr Blood Cancer. 2009 Mar; 52(3):420-2.
Score: 0.005
-
Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura. Am J Hematol. 2008 Dec; 83(12):911-5.
Score: 0.005
-
Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes. 2008 Feb 08; 6:13.
Score: 0.004
-
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008 Feb 02; 371(9610):395-403.
Score: 0.004
-
Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol. 2008 Feb; 83(2):150-4.
Score: 0.004
-
Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study. Transplantation. 2008 Jan 15; 85(1):22-8.
Score: 0.004
-
Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity. Br J Haematol. 2007 Nov; 139(3):486-93.
Score: 0.004
-
A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial. Clin Ther. 2007 May; 29(5):950-962.
Score: 0.004
-
A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation. Health Qual Life Outcomes. 2007 Feb 22; 5:11.
Score: 0.004
-
Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica. 2007 Jan; 92(1):95-100.
Score: 0.004
-
An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura. Br J Haematol. 2007 Jan; 136(1):146-9.
Score: 0.004
-
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med. 2006 Oct 19; 355(16):1672-81.
Score: 0.004
-
The child with immune thrombocytopenic purpura: is pharmacotherapy or watchful waiting the best initial management? A panel discussion from the 2002 meeting of the American Society of Pediatric Hematology/Oncology. J Pediatr Hematol Oncol. 2004 Feb; 26(2):146-51.
Score: 0.003
-
Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries. Am J Med. 2004 Jan 01; 116(1):28-34.
Score: 0.003
-
ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003 Jul 01; 102(1):60-8.
Score: 0.003
-
Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol. 2003 Feb; 25(2):130-3.
Score: 0.003
-
A support group for patients who have recovered from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): The six-year experience of the Oklahoma TTP-HUS Study Group. J Clin Apher. 2003; 18(1):16-20.
Score: 0.003
-
Treatment of drug-induced thrombocytopenia. Expert Opin Drug Saf. 2002 Jul; 1(2):173-80.
Score: 0.003
-
Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome. Transfusion. 2000 Aug; 40(8):896-901.
Score: 0.003
-
Predictive value of compression ultrasonography for deep vein thrombosis in symptomatic outpatients: clinical implications of the site of vein noncompressibility. Arch Intern Med. 2000 Feb 14; 160(3):309-13.
Score: 0.002
-
The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med. 1998 Jan 01; 128(1):1-7.
Score: 0.002
-
Fluorescein derivatization of fibrinogen for flow cytometric analysis of fibrinogen binding to platelets. Cytometry. 1994 Dec 01; 17(4):287-93.
Score: 0.002